J Med Genet

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clayton-Smith, J
Right arrow Articles by Laan, L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clayton-Smith, J
Right arrow Articles by Laan, L
Right arrowPubmed/NCBI databases
*Genetics Home Reference
Journal of Medical Genetics 2003;40:87-95
© 2003 BMJ Publishing Group


REVIEW ARTICLE

Angelman syndrome: a review of the clinical and genetic aspects

J Clayton-Smith1, L Laan2

1 Academic Department of Medical Genetics, St Mary’s Hospital, Manchester, UK
2 Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands

Correspondence to:
Dr J Clayton-Smith, Academic Department of Medical Genetics, St Mary’s Hospital, Hathersage Road, Manchester M13 0JH, UK;
jill.clayton-smith{at}cmmc.nhs.uk]
ABSTRACT
Angelman syndrome ( AS) is a neurodevelopmental disorder characterised by severe learning difficulties, ataxia, a seizure disorder with a characteristic EEG, subtle dysmorphic facial features, and a happy, sociable disposition. Most children present with delay in developmental milestones and slowing of head growth during the first year of life. In the majority of cases speech does not develop. Patients with AS have a characteristic behavioural phenotype with jerky movements, frequent and sometimes inappropriate laughter, a love of water, and sleep disorder. The facial features are subtle and include a wide, smiling mouth, prominent chin, and deep set eyes. It is caused by a variety of genetic abnormalities involving the chromosome 15q11-13 region, which is subject to genomic imprinting. These include maternal deletion, paternal uniparental disomy, imprinting defects, and point mutations or small deletions within the UBE3A gene, which lies within this region. UBE3A shows tissue specific imprinting, being expressed exclusively from the maternal allele in brain. The genetic mechanisms identified so far in AS are found in 85-90% of those with the clinical phenotype and all interfere with UBE3A expression.


Keywords: Angelman syndrome; chromosome 15; genomic imprinting




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Wu, F. V. Bolduc, K. Bell, T. Tully, Y. Fang, A. Sehgal, and J. A. Fischer
A Drosophila model for Angelman syndrome
PNAS, August 26, 2008; 105(34): 12399 - 12404.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
S. Sartori, L. Anesi, R. Polli, I. Toldo, A. Casarin, P. Drigo, and A. Murgia
Angelman Syndrome Due to a Novel Splicing Mutation of the UBE3A Gene
J Child Neurol, August 1, 2008; 23(8): 912 - 915.
[Abstract] [PDF]


Home page
J Child NeurolHome page
W. Braam, R. Didden, M. G. Smits, and L. M. G. Curfs
Melatonin for Chronic Insomnia in Angelman Syndrome: A Randomized Placebo-Controlled Trial
J Child Neurol, June 1, 2008; 23(6): 649 - 654.
[Abstract] [PDF]


Home page
Hum ReprodHome page
S. Bowdin, C. Allen, G. Kirby, L. Brueton, M. Afnan, C. Barratt, J. Kirkman-Brown, R. Harrison, E. R Maher, and W. Reardon
A survey of assisted reproductive technology births and imprinting disorders
Hum. Reprod., December 1, 2007; 22(12): 3237 - 3240.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
C. P. Johnson, S. M. Myers, and and the Council on Children With Disabilities
Identification and Evaluation of Children With Autism Spectrum Disorders
Pediatrics, November 1, 2007; 120(5): 1183 - 1215.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H.-S. Chang, M. D. Anway, S. S. Rekow, and M. K. Skinner
Transgenerational Epigenetic Imprinting of the Male Germline by Endocrine Disruptor Exposure during Gonadal Sex Determination
Endocrinology, December 1, 2006; 147(12): 5524 - 5541.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
T Sahoo, S U Peters, N S Madduri, D G Glaze, J R German, L M Bird, R Barbieri-Welge, T J Bichell, A L Beaudet, and C A Bacino
Microarray based comparative genomic hybridization testing in deletion bearing patients with Angelman syndrome: genotype-phenotype correlations
J. Med. Genet., June 1, 2006; 43(6): 512 - 516.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
A. L. Ham, A. Kumar, R. Deeter, and N. C. Schanen
Does Genotype Predict Phenotype in Rett Syndrome?
J Child Neurol, September 1, 2005; 20(9): 768 - 778.
[Abstract] [PDF]


Home page
J Child NeurolHome page
A. L. Ham, A. Kumar, R. Deeter, and N. C. Schanen
Does Genotype Predict Phenotype in Rett Syndrome?
J Child Neurol, August 1, 2005; 20(8): 768 - 778.
[Abstract] [PDF]


Home page
Hum Mol GenetHome page
K. Makedonski, L. Abuhatzira, Y. Kaufman, A. Razin, and R. Shemer
MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression
Hum. Mol. Genet., April 15, 2005; 14(8): 1049 - 1058.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
E. R. Maher
Imprinting and assisted reproductive technology
Hum. Mol. Genet., April 15, 2005; 14(suppl_1): R133 - R138.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
J A Lamb, G Barnby, E Bonora, N Sykes, E Bacchelli, F Blasi, E Maestrini, J Broxholme, J Tzenova, D Weeks, et al.
Analysis of IMGSAC autism susceptibility loci: evidence for sex limited and parent of origin specific effects
J. Med. Genet., February 1, 2005; 42(2): 132 - 137.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
B. DAN, L. SERVAIS, S. G. BOYD, J. WAGSTAFF, and G. CHERON
From Electrophysiology to Chromatin: A Bottom-Up Approach to Angelman Syndrome
Ann. N.Y. Acad. Sci., December 1, 2004; 1030(1): 599 - 611.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Elgersma, J. D. Sweatt, and K. P. Giese
Mouse Genetic Approaches to Investigating Calcium/Calmodulin-Dependent Protein Kinase II Function in Plasticity and Cognition
J. Neurosci., September 29, 2004; 24(39): 8410 - 8415.
[Full Text] [PDF]


Home page
GeneticsHome page
J. K. Inlow and L. L. Restifo
Molecular and Comparative Genetics of Mental Retardation
Genetics, February 1, 2004; 166(2): 835 - 881.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. R. Maher, M. Afnan, and C. L. Barratt
Epigenetic risks related to assisted reproductive technologies: Epigenetics, imprinting, ART and icebergs?
Hum. Reprod., December 1, 2003; 18(12): 2508 - 2511.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd.